Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Hansen

Showing results (51-60 of 178) with videos related to

Pageof 18
Sort By:
Diabetes, Obesity & Metabolism|January 19, 2017
Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot studyRobert R Henry, Paresh Dandona, Jeremy Pettus, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 30, 2009
Time to change concepts and terminologyDavid Kingdon, Yoshihiro Kinoshita, Paul Hammersley, et al.
European Journal of Human Genetics : EJHG|September 10, 2005
Mutation analysis of the WFS1 gene in seven Danish Wolfram syndrome families; four new mutations identifiedLars Hansen, Hans Eiberg, Timothy Barrett, et al.
Investigative Ophthalmology & Visual Science|February 3, 2009
Comprehensive mutational screening in a cohort of Danish families with hereditary congenital cataractLars Hansen, Annemette Mikkelsen, Peter Nürnberg, et al.
Clinical Pharmacokinetics|May 4, 2023
Pharmacokinetics and Safety of Cotadutide, a GLP-1 and Glucagon Receptor Dual Agonist, in Individuals with Renal Impairment: A Single-Dose, Phase I, Bridging StudyGernot Klein, Marcella Petrone, Ye Yang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 17, 2016
COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN CLEARANCE AND IMPROVES β-CELL FUNCTIONElla Ekholm, Lars Hansen, Eva Johnsson, et al.
American Journal of Medical Genetics. Part A|January 8, 2005
Mapping of hereditary trichilemmal cyst (TRICY1) to chromosome 3p24-p21.2 and exclusion of beta-CATENIN and MLH1Hans Eiberg, Lars Hansen, Claus Hansen, et al.
American Journal of Medical Genetics. Part A|April 27, 2004
Novel Connexin 43 (GJA1) mutation causes oculo-dento-digital dysplasia with curly hairKlaus W Kjaer, Lars Hansen, Hans Eiberg, et al.
Diabetes Care|October 30, 2014
Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metforminJulio Rosenstock, Lars Hansen, Pamela Zee, et al.
American Journal of Medical Genetics. Part A|August 2, 2005
Male-to-male transmission in Laurin-Sandrow syndrome and exclusion of RARB and RARGKlaus W Kjaer, Lars Hansen, Hans Eiberg, et al.
Pageof 18

Showing results (51-60 of 178) with videos related to

Sort By:
Pageof 18
Diabetes, Obesity & Metabolism|January 19, 2017
Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot studyRobert R Henry, Paresh Dandona, Jeremy Pettus, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 30, 2009
Time to change concepts and terminologyDavid Kingdon, Yoshihiro Kinoshita, Paul Hammersley, et al.
European Journal of Human Genetics : EJHG|September 10, 2005
Mutation analysis of the WFS1 gene in seven Danish Wolfram syndrome families; four new mutations identifiedLars Hansen, Hans Eiberg, Timothy Barrett, et al.
Investigative Ophthalmology & Visual Science|February 3, 2009
Comprehensive mutational screening in a cohort of Danish families with hereditary congenital cataractLars Hansen, Annemette Mikkelsen, Peter Nürnberg, et al.
Clinical Pharmacokinetics|May 4, 2023
Pharmacokinetics and Safety of Cotadutide, a GLP-1 and Glucagon Receptor Dual Agonist, in Individuals with Renal Impairment: A Single-Dose, Phase I, Bridging StudyGernot Klein, Marcella Petrone, Ye Yang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 17, 2016
COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN CLEARANCE AND IMPROVES β-CELL FUNCTIONElla Ekholm, Lars Hansen, Eva Johnsson, et al.
American Journal of Medical Genetics. Part A|January 8, 2005
Mapping of hereditary trichilemmal cyst (TRICY1) to chromosome 3p24-p21.2 and exclusion of beta-CATENIN and MLH1Hans Eiberg, Lars Hansen, Claus Hansen, et al.
American Journal of Medical Genetics. Part A|April 27, 2004
Novel Connexin 43 (GJA1) mutation causes oculo-dento-digital dysplasia with curly hairKlaus W Kjaer, Lars Hansen, Hans Eiberg, et al.
Diabetes Care|October 30, 2014
Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metforminJulio Rosenstock, Lars Hansen, Pamela Zee, et al.
American Journal of Medical Genetics. Part A|August 2, 2005
Male-to-male transmission in Laurin-Sandrow syndrome and exclusion of RARB and RARGKlaus W Kjaer, Lars Hansen, Hans Eiberg, et al.
Pageof 18